The Cancer Letter

Inside information on cancer research and drug development

In Brief

Baylor to collaborate with Biocept on blood-based cancer tests

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

BAYLOR COLLEGE OF MEDICINE will collaborate with Biocept Inc. to develop minimally invasive blood-based tests using Biocept’s circulating tumor cell and circulating tumor DNA molecular diagnostic assay platforms to detect mutations in the estrogen receptor gene ESR1.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Table of Contents

Login

Looking for IP Login?